Back to companies

Inventiva SA: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Related keylists

Inventiva SA (Inventiva) is a clinical-stage biopharmaceutical company that develops oral small-molecule therapies for the treatment of fibrosis, lysosomal storage disorders and oncology. Its pipeline products include lanifibranor targets non-alcoholic steatohepatitis; odiparcil for mucopolysaccharidosis; Yap-tead treats non-small cell lung cancer and mesothelioma; and TGF-β for idiopathic pulmonary fibrosis. It has two innovative clinical programs, NATIVE and IMPROVES. It conducts its drug discovery research and development in partnership with various medical organizations such as AbbVie, Abbott, Solvay and Fournier. Inventiva is headquartered in Daix, France.

 Gain a 360-degree view of Inventiva SA and make more informed decisions for your business Gain a 360-degree view of Inventiva SA and make more informed decisions for your business Register your interest
Headquarters France
Address 50 Rue De Dijon, Daix, Bourgogne, 21121
Website inventivapharma.com
Telephone 33 3 80447500
No of Employees 58
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange IVA (NASD)
Revenue (2024) $5.1M -51.3% (2024 vs 2023)
EPS XYZ
Net Income (2024) XYZ -92.2% (2024 vs 2023)
Market Cap* $868.9M
Net Profit Margin (2024) XYZ -294.4% (2024 vs 2023)
* As of and is in US$
View Inventiva SA financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

Products and Services

Products
Pipeline
Lanifibranor: Nonalcoholic Steatohepatitis (NASH)
Odiparcil: Mucopolysaccharidosis Type VI
XYZ
XYZ
XYZ
Understand Inventiva SA portfolio and identify potential areas for collaboration Understand Inventiva SA portfolio and identify potential areas for collaboration Register your interest
Image for loader

Competitor Comparison

Key Parameters Inventiva SA Sanofi NGM Biopharmaceuticals Inc Innate Pharma SA AB Science SA
Headquarters France France United States of America France France
City Daix Paris San Francisco Marseille Paris
State/Province Bourgogne Ile-de-France California Provence - Alpes- Cote d'Azur Ile-de-France
No. of Employees 58 76,493 138 181 37
Entity Type Public Public Private Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Register your interest
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Register your interest
Executives
Name Position Board Since Age
Mark Pruzanski Chairman Executive Board 2024 57
Frederic Cren Chief Executive Officer; Director Executive Board 2016 59
Axel-Sven Malkomes Chief Financial Officer Senior Management 2026 -
Alice Roudot-Ketelers Chief Operating Officer Senior Management 2023 54
Michael Cooreman Chief Medical Officer Senior Management 2020 67
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Inventiva SA key executives to enhance your sales strategy Gain insight into Inventiva SA key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?